Literature DB >> 16511648

A patient with a benign course of neuromyelitis optica (Devic's syndrome) over 12 years: MRI follow up and histological findings.

H Köller, E Neuen-Jacob, A Saleh, B C Kieseier, S Jander, H-P Hartung.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16511648     DOI： 10.1007/s00415-006-0116-0

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  12 in total

1.  The clinical course of neuromyelitis optica (Devic's syndrome).

Authors:  D M Wingerchuk; W F Hogancamp; P C O'Brien; B G Weinshenker
Journal:  Neurology       Date:  1999-09-22       Impact factor: 9.910

2.  MRI and magnetization transfer imaging changes in the brain and cervical cord of patients with Devic's neuromyelitis optica.

Authors:  M Filippi; M A Rocca; L Moiola; V Martinelli; A Ghezzi; R Capra; F Salvi; G Comi
Journal:  Neurology       Date:  1999-11-10       Impact factor: 9.910

3.  Magnetization transfer and diffusion tensor MRI show gray matter damage in neuromyelitis optica.

Authors:  M A Rocca; F Agosta; D M Mezzapesa; V Martinelli; F Salvi; A Ghezzi; R Bergamaschi; G Comi; M Filippi
Journal:  Neurology       Date:  2004-02-10       Impact factor: 9.910

4.  Cerebrospinal fluid findings in Devic's neuromyelitis optica.

Authors:  M Zaffaroni
Journal:  Neurol Sci       Date:  2004-11       Impact factor: 3.307

5.  Neuromyelitis optica: clinical predictors of a relapsing course and survival.

Authors:  Dean M Wingerchuk; Brian G Weinshenker
Journal:  Neurology       Date:  2003-03-11       Impact factor: 9.910

6.  Devic's neuromyelitis optica: clinical, laboratory, MRI and outcome profile.

Authors:  J de Seze; T Stojkovic; D Ferriby; J-Y Gauvrit; C Montagne; F Mounier-Vehier; A Verier; J-P Pruvo; J-C Hache; P Vermersch
Journal:  J Neurol Sci       Date:  2002-05-15       Impact factor: 3.181

7.  Devic's neuromyelitis optica treated with intravenous gamma globulin (IVIG).

Authors:  Jacqueline Bakker; Luanne Metz
Journal:  Can J Neurol Sci       Date:  2004-05       Impact factor: 2.104

8.  Clinical characteristics, course and prognosis of relapsing Devic's Neuromyelitis Optica.

Authors:  Angelo Ghezzi; Roberto Bergamaschi; Vittorio Martinelli; Maria Trojano; M Rosaria Tola; Elisa Merelli; Luigi Mancardi; Paolo Gallo; Massimo Filippi; Mauro Zaffaroni; Giancarlo Comi
Journal:  J Neurol       Date:  2004-01       Impact factor: 4.849

9.  Neuromyelitis optica: importance of cerebrospinal fluid examination during relapse.

Authors:  E Milano; A Di Sapio; S Malucchi; M Capobianco; R Bottero; A Sala; F Gilli; A Bertolotto
Journal:  Neurol Sci       Date:  2003-10       Impact factor: 3.307

10.  IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel.

Authors:  Vanda A Lennon; Thomas J Kryzer; Sean J Pittock; A S Verkman; Shannon R Hinson
Journal:  J Exp Med       Date:  2005-08-08       Impact factor: 14.307
View more
  6 in total

1.  Features of anti-aquaporin 4 antibody-seropositive Chinese patients with neuromyelitis optica spectrum optic neuritis.

Authors:  Hongyang Li; Yanling Wang; Quangang Xu; Aidi Zhang; Huanfen Zhou; Shuo Zhao; Hao Kang; Chunxia Peng; Shanshan Cao; Shihui Wei
Journal:  J Neurol       Date:  2015-07-11       Impact factor: 4.849

2.  Two cases of benign neuromyelitis optica in patients with celiac disease.

Authors:  R Bergamaschi; S Jarius; M Robotti; A Pichiecchio; B Wildemann; G Meola
Journal:  J Neurol       Date:  2009-12       Impact factor: 4.849

3.  Clinical relevance of serum aquaporin-4 antibody levels in neuromyelitis optica.

Authors:  Noriko Isobe; Tomomi Yonekawa; Takuya Matsushita; Katsuhisa Masaki; Satoshi Yoshimura; Jakub Fichna; Shu Chen; Jadwiga Furmaniak; Bernard Rees Smith; Jun-Ichi Kira
Journal:  Neurochem Res       Date:  2013-03-02       Impact factor: 3.996

4.  Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients.

Authors:  Sven Jarius; Klemens Ruprecht; Brigitte Wildemann; Tania Kuempfel; Marius Ringelstein; Christian Geis; Ingo Kleiter; Christoph Kleinschnitz; Achim Berthele; Johannes Brettschneider; Kerstin Hellwig; Bernhard Hemmer; Ralf A Linker; Florian Lauda; Christoph A Mayer; Hayrettin Tumani; Arthur Melms; Corinna Trebst; Martin Stangel; Martin Marziniak; Frank Hoffmann; Sven Schippling; Jürgen H Faiss; Oliver Neuhaus; Barbara Ettrich; Christian Zentner; Kersten Guthke; Ulrich Hofstadt-van Oy; Reinhard Reuss; Hannah Pellkofer; Ulf Ziemann; Peter Kern; Klaus P Wandinger; Florian Then Bergh; Tobias Boettcher; Stefan Langel; Martin Liebetrau; Paulus S Rommer; Sabine Niehaus; Christoph Münch; Alexander Winkelmann; Uwe K Zettl U; Imke Metz; Christian Veauthier; Jörn P Sieb; Christian Wilke; Hans P Hartung; Orhan Aktas; Friedemann Paul
Journal:  J Neuroinflammation       Date:  2012-01-19       Impact factor: 8.322

5.  Connexin 43 astrocytopathy linked to rapidly progressive multiple sclerosis and neuromyelitis optica.

Authors:  Katsuhisa Masaki; Satoshi O Suzuki; Takuya Matsushita; Takeshi Matsuoka; Shihoko Imamura; Ryo Yamasaki; Makiko Suzuki; Toshihiko Suenaga; Toru Iwaki; Jun-Ichi Kira
Journal:  PLoS One       Date:  2013-08-22       Impact factor: 3.240

6.  Atypical Neuromyelitis Optica Spectrum Disorder With Diffuse Cerebral Abnormalities: A Case Report.

Authors:  Braeden D Newton; Orhun Kantarci; Darin T Okuda
Journal:  J Cent Nerv Syst Dis       Date:  2020-11-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.